QY Research recently published a research report, titled, “Global Clozapine Market Professional Survey Report 2019.” According to the report the global clozapine market was valued around US$306 mn in 2018 and is estimated to reach US$411 mn by the end of 2025, rising at a CAGR of more than 4% during 2019-2025.
Get PDF sample copy of this report: https://www.qyresearch.com/sample-form/form/1349547/global-clozapine-market
Increasing Cases of Schizophrenia to Contribute in Market Growth
Global clozapine market is projecting a substantial growth in the healthcare sector owing to its increasing uses in treating psychological ailments. Clozapine is used to treat patients with schizophrenia, schizoaffective disorder, and others. This antipsychotic medication helps restore balance of neurotransmitters by rebalancing dopamine and serotonin to improve thinking, mood, and behaviour. It helps in treating hallucinations, delusions, disorganized thinking, troubled speaking, and other abnormal behaviours. The medication is very effective as it can help to prevent suicide by decreasing hallucinations and other dysfunctions among patients by stimulating clear, positive thinking. The out of this drug is seen via reduced nervousness in patients.
The growing rate of drug abuse such as cannabis and opioids can lead to degeneration of mental faculties, which requires intervention. In such cases, clozapine is used to treat both schizophrenia and drug addiction. In the light of these factors, the analysts project that the market will witness a steady growth rate.
Easy Administration to Boost Oral Segment
Clozapine is usually administrated orally as the tablet easily dissolves upon consumption. Hence, the oral segment is expected to report drastic growth in the forecast years.
North America to Lead Global Market
North America is expected to dominate the market owing to the rising cases of schizophrenia in this region due to drug abuse. The presence of pharmaceutical companies will also fuel the market. Asia Pacific will also grow significantly due to rising awareness about psychological disorders and growing investments from government organisations in the healthcare sector.
Manufacturers to Focus on Different Variants of Clozapine Tablets
Teva Pharmaceuticals has four variants of clozapine tablets including hourglass icon/4359/25, hourglass icon/4404/50, hourglass icon/7772/100, and hourglass icon/4405/200. The company is manufacturing different variants of the drug to reduce side effects by controlling its dosage. This will help healthcare providers to track the intake of clozapine.
The major manufacturers covered in this report includes Mylan, Aurobindo Pharma USA Inc., HLS, Jazz Pharmaceuticals, Sun Pharmaceutical Industries Inc., Teva Pharmaceuticals, Jiangsu Nhwa Pharmaceutical, Mayne Pharma, Qilu Pharmaceutical, Shanghai Pharmaceuticals Sine, Hunan Dongting Pharmaceutical, Dahongying, PIDI, and others.
QY Research established in 2007, focus on custom research, management consulting, IPO consulting, industry chain research, data base and seminar services. The company owned a large basic data base (such as National Bureau of statistics database, Customs import and export database, Industry Association Database etc), expert’s resources (included energy automotive chemical medical ICT consumer goods etc.
QY Research, INC.
17890 Castleton, Suite 218,
Los Angeles, CA – 91748
USA: +1 626 428 8800
China: +86 1082 945 717
Japan: +81 9038 009 273
India: +91 9766 478 224
Emails – email@example.com
Web – www.qyresearch.com